HIF1A and acute kidney injury: Consistently, landiolol hydrochloride, acting as an ultra-short-acting beta-blocker, attenuated LPS-induced AKI by ameliorating HIF-1 upregulation and normalizing inflammatory cytokines such as TNF-α [123].